That is interesting about Phase 1 being difficult to recruit...it makes sense...especially if the treatment is unpleasant or a chore...or breaks too much with the traditional way of doing things.
Ann: Australian Clinical Trials Manager to replace European Role, page-12
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.045(2.86%) |
Mkt cap ! $267.6M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.59 | $1.51 | $156.5K | 101.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3901 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.54 | 1000 | 1 |
View Market Depth
| Last trade - 13.19pm 11/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |